Aminorex, an anorexic agent, was introduced over twenty years
ago for the treatment of obesity. Between 1967 and 1971 its use was associated
with cases of pulmonary hypertension which led to its withdrawal in the Federal
Republic of Germany. WHO has no information to suggest that this drug remains
commercially available.